previous compound ID: 1699 next compound
InChIKey: PIPZGJSEDRMUAW-VJDCAHTMSA-N
SMILES: COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "SD Macknight" "E Matthes" "DY Thomas" "GW Carlile" "JW Hanrahan" "R Robert" "B Kus" "J Liao" "J Goepp"

chemical graph of compound 1699





CID is 6169
synonyms found at PubChem are:
YOHIMBINE HYDROCHLORIDE, 65-19-0, Antagonil, Yohimbe, Yohimbine HCl, Aphrodine hydrochloride, Yohimbine monohydrochloride, Yohimbine (Hydrochloride), UNII-NB2E1YP49F, Yohimbin hydrochloride [USP], EINECS 200-600-4, NSC 19509, NB2E1YP49F, C21H26N2O3.HCl, AI3-60247, 17-Hydroxyyohimban-16-carboxylic acid methyl ester hydrochloride, Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16alpha,17alpha)-, YOHIMBINE CHLORIDE, Yohimbin HCl, CHEMBL537669, 17alpha-Hydroxy-20-alpha-yohimban-16-beta-carboxylic acid, methyl ester, hydrochloride, Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester, hydrochloride, SMR000058527, Yohimbin hydrochloride, SR-01000597896, Dayto-Himbin, SR-01000075297, Yohimbine, HCl, 65-19-0(hcl), Yohimbine hydrochloride [USP:BAN], methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride, Prestwick_961, NSC19509, Yohimbine-Hydrochloride, AC1L1LXU, AC1Q3E9L, MLS001306411, MLS001333983, Yohimbine hydrochloride (USP), MolPort-006-069-047, HMS1569F10, Yohimbine hydrochloride (Antagonil), (1R,2S,4aR,13bS,14aS)-methyl 2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate hydrochloride, ACN-S004280, BCP19708, HY-N0127, NIH 9689, Tox21_501210, CY0011, MFCD00012674, s2373, AKOS015951349, API0004633, CCG-208327, CS-5238, LP01210, MCULE-4460720994, NCGC00094457-01, NCGC00261895-01, AC-22571, AK208923, AS-13939, SY012925, 65-19-0 (HCL), AB1009559, LS-162742, Yohimbine hydrochloride, analytical standard, EU-0101210, N1704, D06671, Y 3125, Yohimbine hydrochloride, >=98% (TLC), powder, 012Y674, Q-201938, SR-01000075297-1, SR-01000597896-1, SR-01000597896-4, Yohimbine hydrochloride, European Pharmacopoeia (EP) Reference Standard, Yohimbine hydrochloride, United States Pharmacopeia (USP) Reference Standard, Antagonil, Yohimbe, Aphrodine hydrochloride, Yohimbine monohydrochloride, 65-19-0, Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride, Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride (8CI), Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16alpha,17alpha)-, ST053522, methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate, chloride, SCHEMBL33955